IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Financials Imeik Technology Development Co.,Ltd.
Equities
300896
CNE100004868
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 215.9 CNY | -2.62% |
|
+0.52% | +2.70% |
| 04-24 | Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-20 | Imeik Technology Development's Profit Rises 47% on Higher Revenue | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 78,733 | 115,993 | 122,535 | 63,540 | 64,950 | - | - |
| Enterprise Value (EV) 1 | 78,733 | 112,737 | 119,407 | 61,121 | 60,966 | 59,056 | 56,645 |
| P/E ratio | 145 x | 121 x | 97 x | 34.2 x | 26.3 x | 20.2 x | 16.4 x |
| Yield | 0.53% | 0.39% | 0.49% | 0.79% | 1.52% | 1.9% | 2.25% |
| Capitalization / Revenue | 111 x | 80.1 x | 63.2 x | 22.1 x | 16.7 x | 12.6 x | 10.1 x |
| EV / Revenue | 111 x | 77.9 x | 61.6 x | 21.3 x | 15.7 x | 11.5 x | 8.83 x |
| EV / EBITDA | 153 x | 99.1 x | 79.4 x | 27.8 x | 21.6 x | 16.1 x | 12.6 x |
| EV / FCF | - | 123 x | 115 x | 32.3 x | 24.8 x | 19.5 x | 15.4 x |
| FCF Yield | - | 0.82% | 0.87% | 3.09% | 4.03% | 5.12% | 6.48% |
| Price to Book | 17.4 x | 23.1 x | 21 x | 10 x | 7.77 x | 5.98 x | 4.69 x |
| Nbr of stocks (in thousands) | 302,904 | 302,904 | 302,904 | 302,232 | 300,805 | - | - |
| Reference price 2 | 259.9 | 382.9 | 404.5 | 210.2 | 215.9 | 215.9 | 215.9 |
| Announcement Date | 08/02/21 | 07/03/22 | 08/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 709.3 | 1,448 | 1,939 | 2,869 | 3,892 | 5,150 | 6,412 |
| EBITDA 1 | 513.7 | 1,137 | 1,504 | 2,195 | 2,821 | 3,659 | 4,485 |
| EBIT 1 | 502.7 | 1,127 | 1,488 | 2,158 | 2,850 | 3,731 | 4,588 |
| Operating Margin | 70.88% | 77.81% | 76.76% | 75.22% | 73.24% | 72.45% | 71.55% |
| Earnings before Tax (EBT) 1 | 502.7 | 1,122 | 1,488 | 2,156 | 2,871 | 3,754 | 4,628 |
| Net income 1 | 439.7 | 957.8 | 1,264 | 1,858 | 2,461 | 3,218 | 3,980 |
| Net margin | 62% | 66.15% | 65.17% | 64.77% | 63.23% | 62.49% | 62.07% |
| EPS 2 | 1.789 | 3.164 | 4.171 | 6.143 | 8.199 | 10.68 | 13.20 |
| Free Cash Flow 1 | - | 919.8 | 1,038 | 1,890 | 2,454 | 3,023 | 3,671 |
| FCF margin | - | 63.52% | 53.55% | 65.88% | 63.06% | 58.7% | 57.25% |
| FCF Conversion (EBITDA) | - | 80.86% | 69.02% | 86.11% | 87% | 82.62% | 81.86% |
| FCF Conversion (Net income) | - | 96.03% | 82.17% | 101.72% | 99.73% | 93.93% | 92.23% |
| Dividend per Share 2 | 1.389 | 1.500 | 2.000 | 1.659 | 3.290 | 4.110 | 4.862 |
| Announcement Date | 08/02/21 | 07/03/22 | 08/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 454.2 | 604.5 | 449.4 | 630.1 | 829.4 | 1,459 | 710.8 | 699 | 808.1 | 1,098 | 1,041 | 956.8 | 1,104 | 1,393 |
| EBITDA 1 | - | 323.7 | - | - | - | - | - | - | - | - | 844.8 | 699.4 | 621.8 | - | - |
| EBIT 1 | - | 361.4 | 470.3 | 328.4 | 485.3 | - | - | 533.1 | 509.5 | 621.9 | 816.7 | 699.4 | 621.8 | - | - |
| Operating Margin | - | 79.56% | 77.8% | 73.09% | 77.02% | - | - | 74.99% | 72.88% | 76.96% | 74.38% | 67.17% | 64.99% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | 485.6 | 630 | - | 533.2 | 506.8 | 622.1 | 844.1 | 726.6 | 657.3 | - | - |
| Net income 1 | 280.1 | - | - | - | 414.1 | 549.3 | 963.4 | 454.9 | 440.2 | 527.4 | 727.6 | 625.4 | 576.9 | - | - |
| Net margin | - | - | - | - | 65.71% | 66.24% | 66.01% | 64% | 62.97% | 65.27% | 66.27% | 60.07% | 60.29% | - | - |
| EPS 2 | 0.9214 | 1.029 | 1.329 | 0.8929 | 1.364 | 1.814 | - | 1.500 | 1.464 | 1.750 | 2.712 | 2.490 | 2.383 | 2.400 | 2.550 |
| Dividend per Share 2 | - | - | - | - | - | 1.320 | - | - | - | - | 2.182 | - | - | - | 2.796 |
| Announcement Date | 26/04/22 | 24/08/22 | 25/10/22 | 08/03/23 | 25/04/23 | 24/08/23 | 24/08/23 | 24/10/23 | 19/03/24 | 24/04/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 3,256 | 3,128 | 2,419 | 3,984 | 5,894 | 8,305 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 920 | 1,038 | 1,890 | 2,454 | 3,023 | 3,671 |
| ROE (net income / shareholders' equity) | 25.3% | 19.1% | 23.7% | 30.1% | 32.8% | 31.6% | 30.8% |
| ROA (Net income/ Total Assets) | 16.4% | 18.5% | 21.9% | 28.4% | 30.8% | 30.9% | 30.5% |
| Assets 1 | 2,688 | 5,184 | 5,762 | 6,555 | 7,998 | 10,420 | 13,032 |
| Book Value Per Share 2 | 15.00 | 16.60 | 19.30 | 21.00 | 27.80 | 36.10 | 46.00 |
| Cash Flow per Share 2 | 1.410 | 3.110 | 3.940 | 6.450 | 7.810 | 10.10 | 12.70 |
| Capex 1 | 32.1 | 23 | 156 | 63.7 | 94.6 | 83 | 95.4 |
| Capex / Sales | 4.52% | 1.59% | 8.03% | 2.22% | 2.43% | 1.61% | 1.49% |
| Announcement Date | 08/02/21 | 07/03/22 | 08/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
215.9
CNY
Average target price
315.9
CNY
Spread / Average Target
+46.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.70% | 8.99B | |
| +9.96% | 125B | |
| -7.13% | 10.97B | |
| -19.67% | 4.86B | |
| +34.49% | 5.38B | |
| +8.18% | 3.43B | |
| -9.55% | 2.78B | |
| -5.57% | 2.22B | |
| -0.60% | 2.21B | |
| -21.53% | 1.82B |
- Stock Market
- Equities
- 300896 Stock
- Financials Imeik Technology Development Co.,Ltd.
